Remove company contact-us
article thumbnail

STAT+: Pharmalittle: Sanofi scraps rare-disease drug deal under FTC pressure; patients regain weight after stopping Lilly’s Zepbound

STAT

As for us, we are as busy as ever hunting and gathering items of interest.  The data, which represents the full results from an 88-week study funded by the company, suggests that people have to stay on the weekly injection if they want to maintain significant weight loss. We trust you have your own hectic agendas.

Diabetes 208
article thumbnail

FDA, Industry Actions End Sales of PFAS Used in US Food Packaging

LifeProNow

The FDA helps to safeguard the food supply by evaluating the use of chemicals as food ingredients and substances that come into contact with food, such as through food packaging, storage or other handling to ensure these uses are safe. consumers from potentially harmful food-contact chemicals.

Packaging 100
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Pharmalittle: Biogen exec who quarterbacked Aduhelm leaves; Pfizer to buy Seagen for $43 billion

STAT

Please feel free to join us. Have a smashing day, and do keep in touch. … Samantha Budd Haeberlein, the Biogen senior executive who supervised the development and controversial approval of the Alzheimer’s treatment Aduhelm, left the company last week , STAT reports. Our choice today is maple bourbon.

217
217
article thumbnail

STAT+: Pharmalittle: We are reading about Catalent concerns, a congressional hearing, and more

STAT

As always, you are invited to join us. The regulator said its Medicine Shortages Single Point of Contact Working Party will meet with member states to gather data on products made at the sites and “assess the possible impact on the availability of these medicines,” but did not provide the names of the drugs in question.

article thumbnail

NOW AVAILABLE: The 2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

Drug Channels

Click here to contact us if you would like to pay by corporate purchase order or check. Please contact us if you did not receive your email. Please contact us if you did not receive your email. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.

article thumbnail

SGD Pharma introduces new range of Type I tubular vials

Express Pharma

A company statement informed, “SGD Pharma’s new Velocity Vial offering reduces the frictional resistance created by glass-to-glass and glass-to-metal contact, helping pharma filing lines to prevent potential disruptions to the flow of vials, which can include tip-overs, jams and glass breakages.

Packaging 108
article thumbnail

Aurobindo Pharma-Walk-In Interviews for Freshers in Production/ Packing On 4th Jan’ 2023

Pharma Pathway

Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceutical manufacturing firm with turnover of over US$2.8 For Further Queries Contact: 7730842888. Aurobindo Pharma-Walk-In Interviews for Freshers in Production/ Packing On 4th Jan’ 2023. Job Description. Time: 09:30 AM to 11:00 AM.